The burden of obesity on infectious disease

Experimental Biology and Medicine

Volumn 235, Issue 12, 2010, Pages 1412-1424

  Karlsson, Erik A ^a   Beck, Melinda A ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b University of North Carolina   (United States)

Author keywords

Adipokine; Immune response; Infection; Obesity; Vaccine

Indexed keywords

ADIPOCYTOKINE; GAMMA INTERFERON; HEPATITIS B VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT HEPATITIS B VACCINE; STAT3 PROTEIN; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; BODY MASS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COXSACKIE VIRUS B4; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; DNA METHYLATION; EFFECTOR CELL; EPIGENETICS; HELICOBACTER INFECTION; HEPATITIS B; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; INFECTION; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; METABOLISM; NATURAL KILLER CELL; NEISSERIA MENINGITIDIS; NUTRITION; OBESITY; RESPIRATORY TRACT INFECTION; SEROCONVERSION; SHORT SURVEY; TETANUS; VACCINATION; WHITE ADIPOSE TISSUE;

ANIMALS; COMMUNICABLE DISEASES; EPIGENESIS, GENETIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LEPTIN; OBESITY; RISK FACTORS; VACCINATION;

ANIMALIA; COXSACKIEVIRUS; ENCEPHALOMYOCARDITIS VIRUS; HELICOBACTER PYLORI; MYCOBACTERIUM TUBERCULOSIS;

EID: 78650040592     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010227     Document Type: Short Survey

References (215)

1. Friedman JM. A war on obesity, not the obese. Science 2003;299:856-8
2. Bellisari A. Evolutionary origins of obesity. Obes Rev 2008;9:165-80
3. Jeffery RW, Harnack LJ. Evidence implicating eating as a primary driver for the obesity epidemic. Diabetes 2007;56:2673-6
4. Pi-Sunyer FX. The Obesity epidemic: pathophysiology and consequences of obesity. Obesity Res 2002;10:97S-104S
5. Pi-Sunyer FX. The medical risks of obesity. Obes Surg 2002;12:6-11
6. Sjostrom L. Morbidity of severely obese subjects. Am J Clin Nutr 1992;55:508S-15
7. Schelbert KB. Comorbidities of obesity. Prim Care 2009;36:271-85
8. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-9
9. Pond CM. Adipose tissue and the immune system. Prostaglandins, Leukot Essent Fatty Acids 2005;73:17-30
10. Martí A, Marcos A, Martínez JA. Obesity and immune function relationships. Obes Rev 2001;2:131-40
11. La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004;4:371-9
12. Anaya DA, Dellinger EP. The obese surgical patient: a susceptible host for infection. Surg Infect 2006;7:473-80
13. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis 2006;6:438-46
14. Canturk Z, Canturk NZ, Cetinarslan B, Utkan NZ, Tarkun I. Nosocomial infections and obesity in surgical patients. Obesity Res 2003;11:769-75
15. Doyle SL, Lysaght J, Reynolds JV. Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev 2009 [Epub ahead of print]
16. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-105
17. Choban PS, Heckler R. Increased incidence of nosocomial infections in obese surgical patients. Am Surg 1995;61:1001
18. Choban PS, Flancbaum L. The impact of obesity on surgical outcomes: a review. J Am Col Surg 1997;185:593-603
19. Koenig SM. Pulmonary complications of obesity. Am J Med Sci 2001;321:249-79
20. Jubber A. Respiratory complications of obesity. Int J Clin Pract 2004;58:573-80
21. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995;310:555-9
22. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000;160:3082-8
23. Jedrychowski W, Maugeri U, Flak E, Mroz E, Bianchi I. Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland. Public Health 1998;112:189-95
24. Dossett LA, Dageforde LA, Swenson BR, Metzger R, Bonatti H, Sawyer RG, May AK. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect 2009;10:137-42
25. Daneman N, Lu H, Redelmeier DA. Discharge after discharge: predicting surgical site infections after patients leave hospital. J Hosp Infect 2010;75:188-94
26. Waisbren E, Rosen H, Bader AM, Lipsitz SR, Rogers SO Jr, Eriksson E. Percent body fat and prediction of surgical site infection. J Am Col Surg 2010;210:381-9
27. Johnson ON III, Sidawy AN, Scanlon JM, Walcott R, Arora S, Macsata RA, Amdur RL, Henderson WG. Impact of obesity on outcomes after open surgical and endovascular abdominal aortic aneurysm repair. J Am Col Surg 2010;210:166-77
28. Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009;250:166-72
29. Dorner TE, Schwarz F, Kranz A, Freidl W, Rieder A, Gisinger C. Body mass index and the risk of infections in institutionalised geriatric patients. Br J Nutr 2010;103:1830-5
30. Arslan E, AtIlgan H, Yavasoglu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Int Med 2009;20:695-7
31. Uberos J, Molina-Carballo A, Fernandez-Puentes V, Rodriguez-Belmonte R, Muaz-Hoyos A. Overweight and obesity as risk factors for the asymptomatic carrier state of Neisseria meningitidis among a paediatric population. Eur J Clin Microbiol Infect Dis 2010;29:333-4
32. Morgan OW, Bramley A, Fowlkes A, Freedman DS, Taylor TH, Gargiullo P, Belay B, Jain S, Cox C, Kamimoto L, Fiore A, Finelli L, Olsen SJ, Fry AM. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 2010;5:e9694
33. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity 2008;17:601-5
34. Yang H, Youm Y-H, Vandanmagsar B, Rood J, Kumar KG, Butler AA, Dixit VD. Obesity accelerates thymic aging. Blood 2009;114:3803-12
35. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, Fagoaga OR. Influence of obesity on immune function. J Am Diet Assoc 1999;99:294-9
36. Nieman DC, Nehlsen-Cannarella SI, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, Rainwater MK. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord 1996;20:353-60
37. O'Rourke R, Kay T, Scholz M, Diggs B, Jobe B, Lewinsohn D, Bakke A. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg 2005;15:1463-8
38. Tanaka S-I, Isoda F, Ishihara Y, Kimura M, Yamakawa T. T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol 2001;54:347-54
39. Lamas O, Marti A, Martinez J. Obesity and immunocompetence. Eur J Clin Nutr 2002;56:S42-5
40. Tanaka S, Inoue S, Isoda F, Waseda M, Ishihara M, Yamakawa T, Sugiyama A, Takamura Y, Okuda K. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 1993;17:631-6
41. O'Shea D, Cawood TJ, O'Farrelly C, Lynch L. Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS ONE 2010;5:e8660
42. Kimura M, Tanaka S-I, Isoda F, Sekigawa K-I, Yamakawa T, Sekihara H. T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sci 1998;62:1243-50
43. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170-80
44. Tanaka S-I, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lymphopenia in genetically obese rats. Clin Immunol Immunopathol 1998;86:219-25
45. Chandra R. Cell-mediated immunity in genetically obese C57BL/6J (ob/ob) mice. Am J Clin Nutr 1980;33:13-6
46. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI, Bloom SR. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999;104:1051-9
47. Fernandes G, Handwerger BS, Yunis EJ, Brown DM. Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest 1978;61:243-50
48. Tanaka S-I, Isoda F, Kiuchi Y, Ikeda H, Mobbs CV, Yamakawa T. T lymphopenia in genetically obese-diabetic wistar fatty rats: effects of body weight reduction on T cells. Metabolism 2000;49:1261-6
49. Lamas O, Martínez JA, Marti A. Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J Nutr Biochem 2004;15:418-25
50. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897-901
51. Meade CJ, Mertin J. Immunological changes associated with the ob/ob (obese) genotype. Proc Nutr Soc 1978;37:38A
52. Macia L, Delacre M, Abboud G, Ouk T-S, Delanoye A, Verwaerde C, Saule P, Wolowczuk I. Impairment of dendritic cell functionality and steady-state number in obese mice. J Immunol 2006;177:5997-6006
53. Mori A, Sakurai H, Choo M-K, Obi R, Koizumi K, Yoshida C, Shimada Y, Saiki I. Severe pulmonary metastasis in obese and diabetic mice. Int J Cancer 2006;119:2760-7
54. Sato-Mito N, Suzui M, Yoshino H, Kaburagi T, Sato K. Long term effects of high fat and sucrose diets on obesity and lymphocyte proliferation in mice. J Nutr Health Aging 2009;13:602-6
55. Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005;42:880-5
56. Mito N, Hosoda T, Kato C, Sato K. Change of cytokine balance in diet-induced obese mice. Metabolism 2000;49:1295-300
57. Verwaerde C, Delanoye A, Macia L, Tailleux A, Wolowczuk I. Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice. Scand J Immunol 2006;64:457-66
58. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 2003;278:46654-60
59. Ordway D, Henao-Tamayo M, Smith E, Shanley C, Harton M, Troudt J, Bai X, Basaraba RJ, Orme IM, Chan ED. Animal model of Mycobacterium abscessus lung infection. J Leukoc Biol 2008;83:1502-11
60. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 2002;168:4018-24
61. Hsu A, Aronoff DM, Phipps J, Goel D, Mancuso P. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Clin Exp Immunol 2007;150:332-9
62. Wieland CW, Florquin S, Chan ED, Leemans JC, Weijer S, Verbon A, Fantuzzi G, van der Poll T. Pulmonary Mycobacterium tuberculosis infection in leptin-deficient ob/ob mice. Int Immunol 2005;17:1399-408
63. Wieland CW, Stegenga ME, Florquin S, Fantuzzi G, van der Poll T. Leptin and host defense against gram-positive and gram-negative pneumonia in mice. Shock 2006;25:414-9
64. Park S, Rich J, Hanses F, Lee JC. Defects in innate immunity predispose C57BL/6J-Leprdb/Leprdb mice to infection by Staphylococcus aureus. Infect Immun 2009;77:1008-14
65. Wehrens A, Aebischer T, Meyer TF, Walduck AK. Leptin receptor signaling is required for vaccine-induced protection against Helicobacter pylori. Helicobacter 2008;13:94-102
66. Ikejima S, Sasaki S, Sashinami H, Mori F, Ogawa Y, Nakamura T, Abe Y, Wakabayashi K, Suda T, Nakane A. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 2005;54:182-9
67. Plotkin BJ, Paulson D, Chelich A, Jurak D, Cole J, Kasimos J, Burdick JR, Casteel N. Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function. J Med Microbiol 1996;44:277-83
68. Webb SR, Loria RM, Madge GE, Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med 1976;143:1239-48
69. Kanda T, Takahashi T, Kudo S, Takeda T, Tsugawa H, Takekoshi N. Leptin deficiency enhances myocardial necrosis and lethality in a murine model of viral myocarditis. Life Sci 2004;75:1435-47
70. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci 2007;104:20466-71
71. Strandberg L, Verdrengh M, Enge M, Andersson N, Amu S, Onnheim K, Benrick A, Brisslert M, Bylund J, Bokarewa M, Nilsson S, Jansson J-O. Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis. PLoS ONE 2009;4:e7605
72. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007;137:1236-43
73. Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology 2009;126:268-79
74. Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985;254:3187-9
75. Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 1986;314:1393
76. Simó Miñana J, Gaztambide Ganuza M, Fernández Millan P, Peña Fernández M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 1996;14:103-6
77. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of Hepatitis B vaccines: implications for persons at occupational risk of Hepatitis B virus infection. Am J Prev Med 1998;15:1-8
78. Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 1993;270:2931-4
79. Young M, Gooch WM III, Zuckerman AJ, Du W, Dickson B, Maddrey WC. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination. J Med Virol 2001;64:290-8
80. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993;270:2935-9
81. Eliakim A, Swindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006;39:137-41
82. Brammer T, Murray EL, Fukuda K, Hall HE, Klimov A, Cox NJ. Surveillance for Influenza - United States, 1997-98, 1998-99, and 1999-00. MMWR Surveill Sum 2002;51:1-10
83. Claycombe K, King LE, Fraker PJ. A role for leptin in sustaining lymphopoiesis and myelopoiesis. Proc Natl Acad Sci 2008;105:2017-21
84. Dinelli MIS, Moraes-Pinto MI. Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder. Rev Inst Med Trop S Paulo 2008;50:129-30
85. Ahmed R, Bevan MJ, Reiner SL, Fearon DT. The precursors of memory: models and controversies. Nat Rev Immunol 2009;9:662-8
86. Ahmed R, Rouse BT. Immunological memory. Immunol Rev 2006;211:5-7
87. Badovinac VP, Harty JT. Programming, demarcating, and manipulating CD8+ T-cell memory. Immunol Rev 2006;211:67-80
88. Beverley PCL. Primer: making sense of T-cell memory. Nat Clin Pract Rheumatol 2008;4:43-9
89. Daniels M, Teixeiro E. The persistence of T cell memory. Cell Mol Life Sci 2010;67:2863-78
90. Jameson SC, Masopust D. Diversity in T cell memory: an embarrassment of riches. Immunity 2009;31:859-71
91. Joshi NS, Kaech SM. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol 2008;180:1309-15
92. Leavy O. T-cell memory: growing with experience. Nat Rev Immunol 2008;8:905
93. Lefrancois L. Development, trafficking and function of memory T-cell subsets. Immunol Rev 2006;211:93-103
94. Lefrancois L, Marzo AL. The descent of memory T-cell subsets. Nat Rev Immunol 2006;6:618-23
95. Obar JJ, Lefrançois L. Memory CD8+ T cell differentiation. Ann NY Acad Sci 2010;1183:251-66
96. Pearce EL, Shen H. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev 2006;211:197-202
97. Rocha B, Tanchot C. The Tower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters and possible dead ends. Immunol Rev 2006;211:182-96
98. Selin LK, Brehm MA, Naumov UN, Cornberg M, Kim S-K, Clute SC, Welsh RM. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006;211:164-81
99. Shaulov A, Murali-Krishna K. CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. J Immunol 2008;180:1131-8
100. Sprent J, Surh CD. T cell memory. Annu Rev Immunol 2002;20:551-79
101. Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol Rev 2006;211:154-63
102. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol 2007;25:171-92
103. Woodland DL. Immunologic memory. Viral Immunol 2007;20:229-30
104. Kaech SM, Wherry EJ. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 2007;27:393-405
105. Harty JT, Badovinac VP. Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol 2008;8:107-19
106. Power C, Miller SK, Alpert PT. Promising new causal explanations for obesity and obesity-related diseases. Biol Res Nurs 2007;8:223-33
107. Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-[alpha] and IL-6. Diabetes Res Clin Pract 2005;69:29-35
108. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, Schauer PR. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004;14:589-600
109. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol 2010;184:3127-33
110. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J Nutr 2010;140:1691-7
111. Wozniak S, Gee L, Wachtel M, Frezza E. Adipose tissue: the new endocrine organ? Dig Dis Sci 2009;54:1847-56
112. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007;18:313-25
113. Trayhurn P, Wood I. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-81
114. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92:347-55
115. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008;37:753-68
116. Axelsson H, Heimbürger O, Lindholm B, Steinvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Renal Nutr 2005;15:131-6
117. Bluher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009;117:241-50
118. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Prac Res Clin Endocrinol Metab 2005;19:547-66
119. Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008;70:537-56
120. Morrison CD. Leptin resistance and the response to positive energy balance. Physiol Behav 2008;94:660-3
121. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol 2003;24:225-53
122. Otero M, Lago R, Lago F, Casanueva FF, Dieguez C, Gomez-Reino JJ, Gualillo O. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 2005;579:295-301
123. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70
124. Prodi E, Obici S. Minireview: the brain as a molecular target for diabetic therapy. Endocrinol 2006;147:2664-9
125. Fogteloo A, Pijl H, Frölich M, McCamish M, Meinders A. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr Metab 2003;16:109-14
126. Farooqi S, Rau H, Whitehead J, O'Rahilly S. ob gene mutations and human obesity. Proc Nutr Soc 1998;57:471-5
127. Licinio J, Caglayan S, Ozata M, Yildiz BO, Miranda PBD, O'Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, McCann SM, Wong M-L. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci 2004;101:4531-6
128. Munzberg H, Bjornholm M, Bates SH, Myers MG. Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 2005;62:642-52
129. Lord GM. Role of leptin in immunology. Nutr Rev 2002;60:S35-7
130. Fantuzzi G. Leptin: nourishment for the immune system. Eur J Immunol 2006;36:3101-4
131. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000;68:437-46
132. Fernández-Riejos P, Najib S, Santos-Alvarez J, Martín-Romero C, Pérez-Pérez A, González-Yanes C, Sánchez-Margalet V. Role of leptin in the activation of immune cells. Mediators Inflamm 2010;2010:568343
133. Velloso LA, Savino W, Mansour E. Leptin action in the thymus. Ann NY Acad Sci 2009;1153:29-34
134. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol 2005;174:3137-42
135. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83
136. Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res Ther 2006;8:217-27
137. Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002;72:330-8
138. Palacio A, Lopez M, Perez-Bravo F, Monkeberg F, Schlesinger L. Leptin levels are associated with immune response in malnourished infants. J Clin Endocrinol Metab 2002;87:3040-6
139. Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, Gabay C. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 2002;168:875-82
140. Martín-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000;199:15-24
141. Procaccini C, Lourenco E, Matarese G, La Cava A. Leptin signaling: a key pathway in immune responses. Curr Signal Transduct Ther 2009;4:22-30
142. Iikuni N, Lam QLK, Lu L, Matarese G, Cava AL. Leptin and inflammation. Curr Immunol Rev 2008;4:70-9
143. La Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004;82:4-11
144. Langhans W. Anorexia of infection: current prospects. Nutrition 2000;16:996-1005
145. Langhans W. Signals generating anorexia during acute illness. Proc Nutr Soc 2007;66:321-30
146. Gualillo O, Eiras S, Lago F, Diéguez C, Casanueva FF. Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci 2000;67:2433-41
147. Savino W, Dardenne M, Velloso LA, Silva-Barbosa SD. The thymus is a common target in malnutrition and infection. Br J Nutr 2007;98:S11-6
148. Scrimshaw N, SanGiovanni J. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 1997;66:464S-77
149. Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukoc Biol 2002;71:16-32
150. Tschop J, Nogueiras R, Haas-Lockie S, Kasten KR, Castaneda TR, Huber N, Guanciale K, Perez-Tilve D, Habegger K, Ottaway N, Woods SC, Oldfield B, Clarke I, Chua S Jr, Farooqi IS, O'Rahilly S, Caldwell CC, Tschop MH. CNS leptin action modulates immune response and survival in sepsis. J Neurosci 2010;30:6036-47
151. MacIver NJ, Jacobs SR, Wieman HL, Wofford JA, Coloff JL, Rathmell JC. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol 2008;84:949-57
152. Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol 2005;5:844-52
153. Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol 2004;172:4661-5
154. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, Plas DR, Elstrom RL, June CH, Thompson CB. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002;16:769-77
155. Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 2007;18:1437-46
156. Gingras A-C, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Develop 2001;15:807-26
157. Edinger AL, Thompson CB. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002;13:2276-88
158. Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity 2007;27:173-8
159. Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 2010;22:314-20
160. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, Larsen CP, Ahmed R. mTOR regulates memory CD8 T-cell differentiation. Nature 2009;460:108-12
161. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang L-S, Jones RG, Choi Y. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009;460:103-7
162. Stanfel MN, Shamieh LS, Kaeberlein M, Kennedy BK. The TOR pathway comes of age. Biochim Biophys Acta 2009;1790:1067-74
163. Romao I, Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J Amer Diet Assoc 2008;108:S24-8
164. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS. Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 1998;47:1089-96
165. Tremblay FDR, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. J Biol Chem 2001;276:38052-60
166. Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009;297:E1247-59
167. Sudarsanam S, Johnson DE. Functional consequences of mTOR inhibition. Curr Opin Drug Discov Devel 2010;13:31-40
168. Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR. DNA methylation and the expanding epigenetics of T cell lineage commitment. Semin Immunol 2005;17:105-19
169. Fitzpatrick DR, Wilson CB. Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 2003;109:37-45
170. Sawalha AH. Epigenetics and T-cell immunity. Autoimmunity 2008;41:245-52
171. Lee C-G, Sahoo A, Im S-H. Epigenetic regulation of cytokine gene expression in T lymphocytes. Yonsei Med J 2009;50:322-30
172. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 2003;4:235-40
173. Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, Hendrich BD, Bird AP, Reiner SL. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 2002;10:81-91
174. Hutchins AS, Artis D, Hendrich BD, Bird AP, Scott P, Reiner SL. Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J Immunol 2005;175:5606-10
175. Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 2003;4:1183-90
176. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Pérez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM, Weaver WM, Kelso A, Jaenisch R, Wilson CB. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001;15:763-74
177. Kersh EN. Impaired memory CD8 T cell development in the absence of methyl-CpG-binding domain protein 2. J Immunol 2006;177:3821-6
178. Milagro FI, Campión J, García-Díaz Laz DF, Goyenechea E, Paternain L, Martínez JA. High fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J Physiol Biochem 2009;65:1-9
179. World Health Organization. Fact Sheet 311: obesity and overweight. Geneva: WHO, 2006. Available at: http://www.who.int/mediacentre/ factsheets/fs311/en/index.html (last checked 12 October 2010)
180. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003;163:2146-8
181. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41
182. Svec P, Vásárhelyi B, Pászthy B, Körner A, Kovács L, Tulassay T, Treszl A. Do regulatory T cells contribute to Th1 skewness in obesity? Exp Clin Endocrinol Diabetes 2007;115:439-43
183. Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA. Effects of weight loss and exercise training on natural killer cell activity in obese women. Med Sci Sport Ex 1998;30:1666-71
184. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001;15:2565-71
185. Lautenbach A, Wrann CD, Jacobs R, Muller G, Brabant G, Nave H. Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals. Obesity 2009;17:1848-55
186. Nave H, Mueller G, Siegmund B, Jacobs R, Stroh T, Schueler U, Hopfe M, Behrendt P, Buchenauer T, Pabst R, Brabant G. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: a novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008;149:3370-8
187. Li S, Sun Y, Liang C-P, Thorp EB, Han S, Jehle AW, Saraswathi V, Pridgen B, Kanter JE, Li R, Welch CL, Hasty AH, Bornfeldt KE, Breslow JL, Tabas I, Tall AR. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res 2009;105:1072-82
188. Lumeng CN, DeYoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007;56:16-23
189. Plotkin BJ, Paulson D. Zucker rat (fa/fa), a model for the study of immune function in type-II diabetes mellitus: effect of exercise and caloric restriction on the phagocytic activity of macrophages. Lab Anim Sci 1996;46:682-4
190. Karastergiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Molec Cell Endocrinol 2010;318:69-78
191. Radin MJ, Sharkey LC, Holycross BJ. Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses. Vet Clin Path 2009;38:136-56
192. Tsatsanis C, Margioris AÂ N, Kontoyiannis DÂ P. Association between H1N1 infection severity and obesity - adiponectin as a potential etiologic factor. J Infect Dis 2010;202:459-60
193. Lago R, Gómez R, Lago F, Gómez-Reino J, Gualillo O. Leptin beyond body weight regulation-Current concepts concerning its role in immune function and inflammation. Cellular Immunol 2008;252:139-45
194. De Rosa V, Procaccini C, Calì G, Pirozzi G, Fontana S, Zappacosta S, La Cava A, Matarese G. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007;26:241-55
195. Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 2006;176:7745-52
196. Mattioli B, Straface E, Matarrese P, Quaranta MG, Giordani L, Malorni W, Viora M. Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin. FASEB J 2008;22:2012-22
197. Lazar MA. Resistin- and obesity-associated metabolic diseases. Horm Metab Res 2007;39:710-6
198. MacDougald OA, Burant CF. The rapidly expanding family of adipokines. Cell Metab 2007;6:159-61
199. Castan-Laurell I, Boucher J, Dray C, Daviaud D, Guigné C, Valet P. Apelin, a novel adipokine over-produced in obesity: rriend or foe? Mol Cell Endocrinol 2005;245:7-9
200. Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, Fernández-Real JM. Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 2010;7:27
201. Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, Shuldiner AR, Fried
202. de Souza Batista CM, Yang R-Z, Lee M-J, Glynn NM, Yu D-Z, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong D-W, Shuldiner AR, Pollin TI, McLenithan JC. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56:1655-61
203. Li Q, Chen R, Moriya J, Yamakawa J, Sumino H, Kanda T, Takahashi T. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res 2008;36:625-9
204. Rosen BS, Cook KS, Yaglom J, Groves DL, Volanakis JE, Damm D, White T, Spiegelman BM. Adipsin and complement factor D activity: an immune-related defect in obesity. Science 1989;244:1483-7
205. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul M-C, Huet P-M, Sadoul J-L, Gugenheim J, Srai SKS, Tran A, Le Marchand-Brustel Y. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006;131:788-96
206. Patke A, Mecklenbräuker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 2006;203:2551-62
207. Kim Y-H, Choi B-H, Cheon H-G, Do M-S. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009;41:208-16
208. Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 2006;18:263-75 (Pubitemid 44287558)
209. Vendrell J, Maymo-Masip E, Tinahones F, Garcia-Espana A, Megia A, Caubet E, Garcia-Fuentes E, Chacon MR. Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin Endocrinol Metab 2010;95:2983-92
210. Alexaki V-I, Notas G, Pelekanou V, Kampa M, Valkanou M, Theodoropoulos P, Stathopoulos EN, Tsapis A, Castanas E. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. J Immunol 2009;183:5948-56
211. Wen Y, Gu J, Li S-L, Reddy MA, Natarajan R, Nadler JL. Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology 2006;147:2518-25
212. Nishikawa T, Edelstein D, Du XL, Yamagishi S-I, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H-P, Giardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-90
213. Dandona P, Chaudhuri A, Mohanty P, Ghanim H. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007;10:511-7
214. Eder K, Baffy N, Falus A, Fulop A. The major inflammatory mediator interleukin-6 and obesity. Inflam Res 2009;58:727-36
215. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1-6